UNSPSC 51102849: Flurandrenolide/neomycin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102849 Flurandrenolide/neomycin is a Commodity code that nominally describes a specific topical corticosteroid-antibiotic combination, yet recent state and local procurement activity under this code shows substantial mismatch. The recent opportunities tagged to this code involve naloxone kits, medical and first aid supplies for emergency response, generic pharmaceuticals distributed through wholesalers, and pharmacy benefit program design—none of which are flurandrenolide/neomycin products. The code appears to be misapplied or used as a catch-all taxonomy marker for pharmaceutical and medical supply procurement across diverse product categories rather than reflecting the narrow scope the code name implies.

Activity sourced to this code spans state health and human services agencies, county health departments, municipal fire departments, and cooperative purchasing alliances. Seminole County, Florida released an IFB on June 30, 2026, for naloxone and drug deactivation systems with a July 26, 2023, response date; the City of Tampa issued an ITB on March 25, 2026, for medical and first aid supplies for its Fire Department Rescue Division (estimated $700,000, designated for certified Small Local Business Enterprises with a 5% bid discount); the Texas Health and Human Services Commission posted an RFI on April 3, 2026, to gather vendor capabilities for a direct-to-manufacturer pharmacy initiative; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP on January 20, 2026, with a March 26, 2026, response date to establish contracts for generic pharmaceuticals and OTC products through authorized wholesalers. The geographic spread includes Florida, Texas, Minnesota, and Oregon through the cooperative purchasing vehicle. Because the tagged opportunities do not reflect the code's stated pharmaceutical scope, procurement professionals should verify actual commodity codes against posted solicitation details rather than rely on the nominal taxonomy assignment.